QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 510 participants.
Also called NCT07444086
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 510 participants
- Registry
-
NCT07444086
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07444086. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-05 (anticipated); primary completion 2027-10-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia
- Condition
- Primary Hypercholesterolemia or Mixed Hyperlipidemia
- Intervention (Drug)
- QLC7401
- Intervention (Drug)
- Placebo
- Lead sponsor
- Qilu Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct07444086- Content hash
32e9e5ddf73c820a5b3734f2ac098441381de11fc2287e5e4b99f54e27eb8397